Digestive & Intestinal Remedies (Pharmacies) - Serbia

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$30.56m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 6.36%, resulting in a market volume of US$41.60m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$4.31 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Serbia is experiencing steady growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Serbia are shifting towards natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived to be safer and have fewer side effects. This preference for natural remedies is driving the demand for digestive and intestinal remedies made from herbal ingredients. Additionally, consumers are also looking for products that provide long-term relief and address the root cause of digestive issues, rather than just providing temporary relief. Trends in the market indicate a growing demand for probiotic supplements and digestive enzymes. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help restore the natural balance of bacteria in the gut and improve digestion. Digestive enzymes, on the other hand, help break down food and aid in the absorption of nutrients. These trends are driven by the increasing awareness of the importance of gut health and the role it plays in overall well-being. Local special circumstances in Serbia, such as a traditional diet rich in fermented foods, also contribute to the growth of the Digestive & Intestinal Remedies (Pharmacies) market. Fermented foods like yogurt and sauerkraut are known to contain probiotics that promote healthy digestion. The familiarity with these foods and their benefits has created a favorable environment for the acceptance and adoption of digestive remedies in the market. Underlying macroeconomic factors, such as the increasing disposable income and improving healthcare infrastructure in Serbia, are also driving the growth of the Digestive & Intestinal Remedies (Pharmacies) market. As the standard of living improves, consumers are willing to spend more on healthcare products and services. This includes investing in digestive and intestinal remedies to maintain their digestive health. The availability of a wide range of products in pharmacies and the accessibility of healthcare services further support the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Serbia is developing due to changing customer preferences towards natural and herbal remedies, emerging trends in the market such as probiotic supplements and digestive enzymes, local special circumstances like the traditional diet rich in fermented foods, and underlying macroeconomic factors such as increasing disposable income and improving healthcare infrastructure.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.